Hexaxim Drug Interactions

Data on concomitant administration of Hexaxim with a pneumococcal polysaccharide conjugated vaccine have shown no clinically relevant interference in the antibody response to each of the antigens.
Data on concomitant administration of a booster dose of Hexaxim with measles-mumps-rubella vaccines have shown no clinically relevant interference in the antibody response to each of the antigens. There may be a clinically relevant interference in the antibody response of Hexaxim and a varicella vaccine and these vaccines should not be administered at the same time.
Data on concomitant administration of rotavirus vaccines have shown no clinically relevant interference in the antibody response to each of the antigens.
Data on concomitant administration of Hexaxim with a meningococcal C conjugate vaccine or a meningococcal group A, C, W-135 and Y conjugate vaccine have shown no clinically relevant interference in the antibody response to each of the antigens.
If co-administration with another vaccine is considered, immunisation should be carried out on separate injections sites.
Hexaxim must not be mixed with any other vaccines or other parenterally administered medicinal products.
No significant clinical interaction with other treatments or biological products has been reported except in the case of immunosuppressive therapy (see Precautions).
Interference with laboratory testing: see Precautions.